Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

(2012) Jie Ni et al.   CANCER AND METASTASIS REVIEWS

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma

(2012) Christian Eichelberg et al.   INTERNATIONAL JOURNAL OF CANCER

Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

(2011) Carlo Patriarca et al.   CANCER TREATMENT REVIEWS

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

What can molecular pathology contribute to the management of renal cell carcinoma?

(2011) Grant D. Stewart et al.   Nature Reviews Urology

EAU Guidelines on Renal Cell Carcinoma: The 2010 Update

(2010) Börje Ljungberg et al.   EUROPEAN UROLOGY

Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy

(2009) T. Klatte et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy

(2009) Marianna Sabatino et al.   JOURNAL OF CLINICAL ONCOLOGY

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY